Skip to content
Biodatica
Start free

GCP-Service International West GmbH

Grenoble

Oncologysmall moleculePhase III
Compare Sign in to watch

What changed

Phase III trial registered: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

7w agoTrial registeredMay 29, 2026Source filing (opens the source filing in a new tab)

Momentum

81no change

Momentum 81 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

672 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Sep 10, 2024

    Low Risk Myelodysplastic Syndromes · ACTIVE_NOT_RECRUITING · sponsor: GCP-Service International West GmbH · RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

    ClinicalTrials.gov · NCT06243458 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jun 5, 2023

    Myelodysplastic Syndromes, Acute Myeloid Leukemia · ACTIVE_NOT_RECRUITING · sponsor: GCP-Service International West GmbH · Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy

    ClinicalTrials.gov · NCT05583552 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Jul 19, 2017

    Myelodysplastic Syndromes · COMPLETED · sponsor: Technische Universität Dresden · Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly

    ClinicalTrials.gov · NCT02867085 (opens the source filing in a new tab)

  4. Trial

    PHASE3 registered

    Jun 1, 2016

    Acute Promyelocytic Leukemia · COMPLETED · sponsor: Technische Universität Dresden · Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

    ClinicalTrials.gov · NCT02688140 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources